Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer.
Journal: Gynecologic oncology
Published: April 23, 2014
Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2013
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 21, 2011
Showing 1-3 of 3
Last Updated: 09/26/2026